Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
23
Number of overlapping holdings
51.1%
% of CANC's 45 holdings also in CNCR
30.7%
% of CNCR's 75 holdings also in CANC
Overlap by Weight
Sector Drift (CANC minus CNCR)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in CANC |
Weight in CNCR |
Overlap | |
|---|---|---|---|---|
 |
REVOLUTION MEDICINES, INC. | 3.1% | 1.5% | 1.5% |
|
DAY ONE BIOPHARMACEUTICALS, INC. | 2.1% | 1.5% | 1.5% |
|
MERCK & CO. INC. | 5.6% | 1.5% | 1.5% |
|
EXELIXIS INC | 2.4% | 1.4% | 1.4% |
|
BLUEPRINT MEDICINES CORP. | 2.6% | 1.4% | 1.4% |
Position Highlights (Non-Overlapping Exposures)
CANC Overweight Relative to CNCR
|
REGENERON PHARMACEUTICALS | 4.3% |
|
MERCK & CO. INC. | 4.1% |
 |
DAIICHI SANKYO CO LTD | 4.0% |
 |
ASTRAZENECA PLC | 3.8% |
 |
NOVARTIS AG | 3.7% |
|
ILLUMINA INC | 3.5% |
|
EXACT SCIENCES CORP | 3.1% |
 |
ARGENX SE ADR | 2.9% |
|
GILEAD SCIENCES INC | 2.9% |
|
CHUGAI PHARMACEUTICAL CO LTD | 2.7% |
CANC Underweight Relative to CNCR
|
GERON CORP | -3.0% |
|
ACRIVON THERAPEUTICS, INC. | -2.6% |
|
ENLIVEN THERAPEUTICS, INC. | -2.1% |
|
JANUX THERAPEUTICS, INC. | -1.8% |
|
NUVATION BIO INC CLASS A | -1.7% |
|
2SEVENTY BIO, INC. | -1.6% |
|
IMMUNITYBIO INC | -1.5% |
|
LYELL IMMUNOPHARMA, INC. | -1.4% |
|
Y-MABS THERAPEUTICS, INC. | -1.4% |
 |
MORPHOSYS AG SPONSORED ADR | -1.4% |